Medical Devices

GRIN Therapeutics expands its pivotal Phase 3 study for radiprodil to Europe, fueling hope for a first-ever targeted therapy for a rare neurological disorder.

Spanish CDMO ROIS acquires a major Phoenix facility from Bristol Myers Squibb, securing US drug supply chains and expanding its global footprint.

New FDA clearance for Hepatoscope adds spleen exams and industry-first compliance, changing how clinicians manage liver disease at the point of care.

A new company emerges from Purdue Pharma's bankruptcy, owned by a non-profit and tasked with fighting the very opioid crisis its predecessor fueled.

The medical device manufacturer appoints the former Corza Medical CEO to manage its rapid expansion and solidify its leadership in a competitive global market.

Pivotal trial results for a 3D-printed surgical guide show a dramatic drop in follow-up surgeries, heralding a new era of precision for patients.

As demand for complex medical flights soars, a specialized industry of 'flying ICUs' navigates immense logistical and medical hurdles to save lives.

Former Gov. Larry Hogan, a cancer survivor, joins the board of radiology giant RP, blending public health policy with a push for AI-driven diagnostics.

TaeWoong Medical USA's new FDA-cleared SPAXUS stent offers a safer, minimally invasive option for complex pancreatic and gallbladder drainage procedures.

With new FDA clearance, Zeta Surgical's portable AI navigation system could bring millimeter-precision brain surgery to any hospital, not just elite centers.

A new software-only approach from Retia Medical promises to turn routine monitors into powerful cardiac tools, democratizing critical care without new hardware.

Amid record growth, the supply platform adds top advisors Oliver Gelles and Dr. Anil Idiculla and prepares to launch a new AI invoice verification tool.

A new partnership brings the Aplio i800 EUS to the U.S., offering advanced imaging to improve early, less invasive diagnosis of complex GI conditions.

Medcura adds a Johnson & Johnson heavyweight to its board, aiming to disrupt the surgical hemostasis market with its FDA-designated breakthrough gel, LifeGel.

A new partnership aims to create a continuous data stream from surgery to recovery, using AI to predict and prevent costly gastrointestinal complications.

Diakonos Oncology's personalized therapy, DOC1021, reports impressive survival data in early trials for glioblastoma and pancreatic cancer.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

Strata Critical Medical acquires Ohio Valley Perfusion Associates, a strategic move to consolidate the fragmented perfusion market and boost lifesaving care.

Mount Sinai adopts Echo IQ's AI to improve detection of aortic stenosis, a deadly but often-missed heart condition, heralding a new era for cardiac care.